CFRA analyst Jonathan Sakraida raised the price target on POINT Biopharma Global Inc. (NASDAQ: PNT) to $105.00 (from $100.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE